Try our Advanced Search for more refined results
August 11, 2011
Thorn v. Novartis Pharmaceuticals Corporation (PLR1)
Case Number:
3:11-cv-00373
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
December 17, 2012
Novartis Gets Expert Testimony Blocked In Aredia-Zometa MDL
A Tennessee federal judge on Thursday barred portions of expert testimony in cases stemming from multidistrict litigation against Novartis Pharmaceuticals Corp. over jaw damage blamed on osteoporosis drugs Aredia and Zometa, calling the witness unqualified to speak about links between the medications and bone loss.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login